Highlights and Quick Summary
- Financing cash flow for the quarter ending September 30, 2023 was $-924 Thousand (a -24.26% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow decreased by -166.33%
- Annual Financing cash flow for 2022 was $5.24 Million (a -98.44% decrease from previous year)
- Annual Financing cash flow for 2021 was $336 Million (a 373.69% increase from previous year)
- Annual Financing cash flow for 2020 was $71 Million (a 458.58% increase from previous year)
- Twelve month Financing cash flow ending September 30, 2023 was $-1.86 Million (a 0.16% increase compared to previous quarter)
- Twelve month trailing Financing cash flow decreased by -135.42% year-over-year
Trailing Financing cash flow for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-1.86 Million | $-1.85 Million | $5.19 Million | $5.24 Million |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of Absci Corporation
Most recent Financing cash flowof ABSI including historical data for past 10 years.Interactive Chart of Financing cash flow of Absci Corporation
Absci Corporation Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-0.92 | $-1.22 | $-1.1 | – | – |
| 2022 | $1.39 | $-0.92 | $5.82 | $-1.06 | $5.24 |
| 2021 | $-1.3 | $208.39 | $-0.47 | $129.58 | $336.19 |
| 2020 | $64.39 | $-0.31 | $6.33 | $0.57 | $70.97 |
| 2019 | $12.71 | – | – | – | $12.71 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology